Literature DB >> 29364017

VRAM steal syndrome - a unique cause of flap necrosis in chest wall reconstruction.

S Young1, N Pantelide1, S Iyer1.   

Abstract

The pedicled vertical rectus abdominis myocutaneous (VRAM) flap is a robust flap, which is considered to be a 'workhorse' regional option for chest wall reconstruction. We describe a previously unreported complication of partial flap loss due to 'steal syndrome', whereby arterial supply was diverted away from the flap due to dialysis from an ipsilateral arteriovenous fistula.

Entities:  

Keywords:  Arteriovenous fistula; Coronary artery bypass grafting; Pedicled flap; Rectus abdominis; Steal syndrome

Mesh:

Year:  2018        PMID: 29364017      PMCID: PMC5930105          DOI: 10.1308/rcsann.2017.0228

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  3 in total

1.  Internal mammary artery steal in a dialysis patient.

Authors:  Hiroshi Kato; Seiichiro Ikawa; Akio Hayashi; Kenji Yokoyama
Journal:  Ann Thorac Surg       Date:  2003-01       Impact factor: 4.330

2.  Coronary steal from a left internal mammary artery coronary bypass graft by a left upper extremity arteriovenous hemodialysis fistula.

Authors:  Steven D Crowley; David W Butterly; Robert H Peter; Steve J Schwab
Journal:  Am J Kidney Dis       Date:  2002-10       Impact factor: 8.860

3.  Risks of using internal thoracic artery grafts in patients in chronic hemodialysis via upper extremity arteriovenous fistula.

Authors:  Mario Gaudino; Michele Serricchio; Nicola Luciani; Stefania Giungi; Andrea Salica; Roberto Pola; Paolo Pola; Giovanna Luciani; Gianfederico Possati
Journal:  Circulation       Date:  2003-05-19       Impact factor: 29.690

  3 in total
  1 in total

Review 1.  Surgical Outcomes of VRAM vs. Gracilis Flaps in Vulvo-Perineal Reconstruction Following Oncologic Resection: A Proportional Meta-Analysis.

Authors:  Ebai A Eseme; Matteo Scampa; Juan A Viscardi; Myriam Ebai; Daniel F Kalbermatten; Carlo M Oranges
Journal:  Cancers (Basel)       Date:  2022-09-01       Impact factor: 6.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.